Even if patients achieve adequate control of their blood sugar levels, drugs other than GLP-1 agonists may have different side effect profiles
: ( )
Hm lng Biotin (vitamin H) cn b sung hng ngy ph thuc vo tui ca bn, c th: Tr em 1 - 3 tui: 8mcg/ngy Tr em 4 - 8 tui: 12mcg/ngy Tr em 9 - 13 tui: 20mcg/ngy Thanh thiu nin 14 - 18 tui: 25mcg/ngy Ngi ln trn 18 tui: 30mcg/ngy Ph n mang thai v cho con b: 35mcg/ngy Ty thuc vo tnh trng sc khe c th, bc s c th k liu cao hn
Currently available GLP-1 medications in the United States include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), exenatide extended-release (Bydureon BCise), and tirzepatide (Mounjaro, Zepbound)with tirzepatide being a dual GIP/GLP-1 receptor agonist rather than a pure GLP-1 agonist
While the physiological roles of Ferroptosis are still being elucidated, it has been implicated in a variety of human diseases as described below